Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
20051.7k citationsAnthony Howell, Jack Cuzick et al.The Lancetprofile →
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
20021.5k citationsM Baum et al.The Lancetprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of M Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Baum more than expected).
This network shows the impact of papers produced by M Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Baum. The network helps show where M Baum may publish in the future.
Co-authorship network of co-authors of M Baum
This figure shows the co-authorship network connecting the top 25 collaborators of M Baum.
A scholar is included among the top collaborators of M Baum based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with M Baum. M Baum is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Baum, M, Jayant S. Vaidya, Mohammed Keshtgar, et al.. (2010). TARGIT (TARGETED INTRA-OPERATIVE RADIOTHERAPY FOR EARLY STAGE BREAST CANCER): RESULTS FROM THE TARGIT A RANDOMIZED CONTROLLED TRIAL. UCL Discovery (University College London).1 indexed citations
3.
Baum, M, et al.. (2009). Breast cancer screening peril Negative consequences of the breast screening programme. UCL Discovery (University College London).2 indexed citations
4.
Howell, Anthony, Jack Cuzick, M Baum, et al.. (2005). Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. The Lancet. 365(9453). 60–62.1715 indexed citations breakdown →
Vaidya, Jayant S., Andrew Wilson, Samuele Massarut, et al.. (2003). Cosmetic outcome after targeted intraoperative radiotherapy (TARGIT) for early breast cancer. UCL Discovery (University College London).8 indexed citations
7.
Douek, Michael & M Baum. (2003). Mass breast screening: is there a hidden cost?. British journal of surgery. 90. 44–45.19 indexed citations
8.
Baum, M. (2002). Anastozole (A) is superior to tamoxifen (T) in treatment of postmenopausal (PM) women with early breast cancer (EBC) - First results of the ATAC (Arimidex, tamoxifen, alone or in combination) trial (on behalf of the ATAC Trialists' Group). UCL Discovery (University College London).191 indexed citations
9.
Rothman, Kenneth J., M Baum, & Karin B. Michels. (2000). For and against. Europe PMC (PubMed Central). 321(7258). 442–445.34 indexed citations
Nicholson, Robert I., Julia M.W. Gee, Colby L. Eaton, et al.. (1994). Pure antioestrogens in breast cancer - experimental and clinical observations. ORCA Online Research @Cardiff.3 indexed citations
Saunders, Christobel & M Baum. (1993). Breast Cancer and Pregnancy: A Review. Journal of the Royal Society of Medicine. 86(3). 162–165.44 indexed citations
Baum, M. (1983). Commentaries on Research in Breast Disease, vol 2. Journal of the Royal Society of Medicine. 76(9). 805–805.3 indexed citations
18.
Baum, M. (1980). The management of advanced breast cancer.. PubMed. 23(1). 32, 35, 37–9.4 indexed citations
19.
Baum, M, et al.. (1979). Spleen size in women with breast cancer.. PubMed. 5(4). 317–23.6 indexed citations
20.
Baum, M. (1967). Lesser sac apoplexy. The American Journal of Surgery. 113(5). 688–691.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.